(Q40952446)

25 September 2017

1 reference

title

Risks and benefits of retinoids in the chemoprevention of cancer (English)

1 reference

25 September 2017

G de Palo

1

1 reference

PubMed ID

8573297

25 September 2017

F Formelli

series ordinal

2

1 reference

25 September 2017

1 October 1995

1 reference

25 September 2017

1 reference

25 September 2017

13

1 reference

25 September 2017

245-256

1 reference

25 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199513040-00004

25 September 2017

0 references

cites work

Chemoprevention of breast cancer with retinoids

1 reference

12 December 2020

Acute promyelocytic leukemia

1 reference

12 December 2020

Ocular toxic effects of fenretinide

1 reference

12 December 2020

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

1 reference

12 December 2020

Recruitment for an efficacy study in chemoprevention--the Concerned Smoker Study.

1 reference

12 December 2020

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial

1 reference

12 December 2020

Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer

1 reference

12 December 2020

Cancer chemoprevention

1 reference

12 December 2020

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

12 December 2020

Etretinate in treatment of actinic keratosis. A double-blind crossover study

1 reference

12 December 2020

Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint

1 reference

12 December 2020

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients

1 reference

12 December 2020

Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats

1 reference

12 December 2020

Abnormal retinal function associated with fenretinide, a synthetic retinoid

1 reference

12 December 2020

Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide

1 reference

12 December 2020

An overview of the retinoids

1 reference

12 December 2020

A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy

1 reference

12 December 2020

Use of screening phase data to evaluate observer variation of sputum cytodiagnosis as an outcome measure in a chemoprevention trial.

1 reference

12 December 2020

Biomarkers as intermediate end points in chemoprevention trials

1 reference

12 December 2020

Preventative effect of etretinate therapy on multiple actinic keratoses.

1 reference

12 December 2020

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients

1 reference

12 December 2020

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

12 December 2020

Prevention of Recurrent Superficial Bladder Tumors by Oral Etretinate: Preliminary Results of a Randomized, Double Blind Multicenter Trial in Switzerland

1 reference

12 December 2020

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results

1 reference

12 December 2020

Newly administered [3H]retinol is transferred from hepatocytes to stellate cells in liver for storage

1 reference

12 December 2020

Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.

1 reference

12 December 2020

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

1 reference

12 December 2020

The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients

1 reference

12 December 2020

Retinoids as preventive and therapeutic anticancer agents (Part I).

1 reference

12 December 2020

Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne

1 reference

12 December 2020

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

1 reference

12 December 2020

Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients

1 reference

12 December 2020

Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions

1 reference

12 December 2020

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

1 reference

12 December 2020

Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment

1 reference

12 December 2020

Results of the use of vitamin A and retinoids in cutaneous malignancies

1 reference

12 December 2020

Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology

1 reference

12 December 2020

N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat

1 reference

12 December 2020

Chemoprevention of breast cancer

1 reference

12 December 2020

Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group

1 reference

12 December 2020

Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours

1 reference

12 December 2020

Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse

1 reference

12 December 2020

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)

1 reference

12 December 2020

Chemoprevention strategies for lung and upper aerodigestive tract cancer

1 reference

12 December 2020

Oncogenes and human lung cancer

1 reference

12 December 2020

Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin

1 reference

12 December 2020

Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy

1 reference

12 December 2020

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

12 December 2020

Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor

1 reference

12 December 2020

Chemoprevention of cancer with retinoids

1 reference

12 December 2020

Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute.

1 reference

12 December 2020

Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).

1 reference

12 December 2020

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

1 reference

12 December 2020

Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer

1 reference

12 December 2020

Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity

1 reference

12 December 2020

Can fenretinide protect women against ovarian cancer?

1 reference

12 December 2020

Epidemiology of isotretinoin exposure during pregnancy

1 reference

12 December 2020

Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects

1 reference

12 December 2020

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

1 reference

12 December 2020

13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

1 reference

12 December 2020

1 reference

12 December 2020

Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial

1 reference

12 December 2020

Fenretinide (4-HPR) in chemoprevention of oral leukoplakia

1 reference

12 December 2020

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

1 reference

12 December 2020

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.

1 reference

12 December 2020

10.2165/00002018-199513040-00004

Identifiers

DOI

1 reference

PubMed ID

8573297

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8573297